Cargando…
Two COX-2 inhibitors induce apoptosis in human erythroleukemia K562cells by modulating NF-κB and FHC pathways
BACKGROUND: Leukemia is distinguished by abnormal proliferation of leukocytes. Although there has been some progress in developing novel cancer therapies, no significant improvement was observed in the overall survival rate over the last decade. Selective cyclooxygenase-2 (COX-2) inhibitors are know...
Autores principales: | Norouzi, Shaghayegh, Norouzi, Mahnaz, Amini, Mohsen, Amanzadeh, Amir, Nabiuni, Mohamad, Irian, Saeed, Salimi, Mona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4704250/ https://www.ncbi.nlm.nih.gov/pubmed/26739353 http://dx.doi.org/10.1186/s40199-015-0139-0 |
Ejemplares similares
-
Anti-proliferative activity of Fumaria vaillantii extracts on different cancer cell lines
por: Tabrizi, Fatemeh Haji Abbas, et al.
Publicado: (2016) -
Effect of the Hydroalcoholic Extract of Heracleum persicum (Golpar) on Folliculogenesis in Female Wistar Rats
por: Hemati, Atefeh, et al.
Publicado: (2012) -
NF90/ILF3 is a transcription factor that promotes proliferation over differentiation by hierarchical regulation in K562 erythroleukemia cells
por: Wu, Ting-Hsuan, et al.
Publicado: (2018) -
Diverse Effects of Glutathione and UPF Peptides on Antioxidant Defense System in Human Erythroleukemia Cells K562
por: Kairane, Ceslava, et al.
Publicado: (2012) -
K562 erythroleukemia line as a possible reticulocyte source to culture Plasmodium vivax and its surrogates
por: Kronstein-Wiedemann, Romy, et al.
Publicado: (2020)